Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$37.76 - $63.00
Next Earnings Date
May 14 2025
Next Earnings Date
May 14 2025
Latest price
Market Cap | $2.01B |
EV | $1.99B |
Shares Outstanding | 51.41M |
Beta | 1.62 |
Analyst Rating | BUY |
Analyst Target Price | $63.25 |
P/E 2025E | 123.87x |
P/Revenue 2025E | 7.01x |
Revenue | 15.00% |
EPS | - |
Operating Cash Flow | 26.10% |
Free Cash Flow | - |
Revenue | 23.20% |
EPS | 85.20% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 73.68% |
Net Profit Margin 2025E | 5.80% |
ROE 2025E | - |
ROCE 2024 | 4.00% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Vericel Corporation
VCEL
Sector
Healthcare
Industry
Biotechnology
CEO
Colangelo, Dominick
Employees
357
Website
vcel.comIPO Date
1997-02-04
Headquarters
64 Sidney Street, Cambridge, Massachusetts, 02139, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved